Clin2
NCT07106008Possibly a fitNot yet recruiting

Imaging brain tumors with a special tracer

Glioma (Any Grade) in the Brain

Part of Cancer clinical trials.

This trial tests a new imaging tracer that may help doctors see brain tumors (gliomas) more clearly before surgery. It could help guide treatment and is for people scheduled for surgery or biopsy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
8 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You have a brain lesion seen on CT or MRI, and you are scheduled for surgery or biopsy.
  • Your kidney function, blood counts, and liver function are within safe limits.
  • You have not had chemotherapy in the last 6 months, and you are expected to live at least 6 more months.
  • You are not pregnant or breastfeeding, and you have no serious allergies or infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07698457Not yet recruiting· Phase 3
PET imaging for suspected brain tumors

This study tests a special imaging method to look at brain tumors before surgery. It uses a tracer that may help doctors see tumors more clearly.

Taoyuan City, Fuxing St., Guishan Dist.
NCT06650163Recruiting· Phase 1
New imaging test for brain tumor surgery planning

This trial tests a new kind of PET scan that uses a special tracer (Zr-89 crefmirlimab berdoxam) to help doctors see brain tumors more clearly before surgery. If you are scheduled to have your brain tumor removed, this scan may give your surgeon extra information to guide the operation.

Los Angeles, California
NCT05263466Not yet recruiting
Imaging agent to highlight brain tumours before surgery

This study uses a special imaging agent (called PSMA) that may help doctors see brain tumours more clearly during scans. It aims to find out if this agent can better identify aggressive brain tumours, especially gliomas, before surgery.

London
NCT06199479Recruiting· Phase 1
Using imaging to tell real tumor growth from treatment effects

This trial uses special imaging to tell the difference between real brain tumor growth and a treatment reaction that looks like a tumor. It may help you and your doctor decide if a biopsy is needed.

Houston, Texas
NCT07023640Recruiting
Imaging test for tumors using a new tracer agent

This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.

Beijing, Beijing Municipality
NCT07567196Recruiting
PET imaging to guide surgery for aggressive brain tumors

This trial tests whether using a special PET scan (a type of imaging that shows tumor activity) during brain tumor surgery helps doctors remove more of the tumor safely. You would have a high-grade glioma (an aggressive brain cancer) and be scheduled for surgery.

Torino, Turin

Hear when a new Glioma (Any Grade) in the Brain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.